Our US-based healthcare professionals can answer your questions about GLP-1 agonists, and are able to prescribe appropriate medication if its clinically indicated
You J, Yang C, Han J, Wang H, Zhang W, Zhang Y, Lu Z, Wang S, Cai R, Li H, Yu J, Gao J, Zhang Y, Gu Z
Antioxidants (basel) 12(1):123
The definitive impact of tirzepatide on cardiovascular disease will be addressed in the ongoing SURPASS-COVT study (ClinicalTrials.gov number, NCT04255433), which compares tirzepatide with dulaglutide in patients with T2DM and ASCVD
[7] [9] Use is also contraindicated in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency, as high doses of ascorbic acid may induce hemolysis in this population